152 related articles for article (PubMed ID: 9809344)
1. [Beta-2 agonists].
Devillier P
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S45-50. PubMed ID: 9809344
[No Abstract] [Full Text] [Related]
2. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
Muir JF; Cuvelier A
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
[No Abstract] [Full Text] [Related]
3. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against].
Terrioux P
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258
[No Abstract] [Full Text] [Related]
4. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
Norman P
Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
Ray NC; Alcaraz L
Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
[TBL] [Abstract][Full Text] [Related]
6. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
7. [Update on beta-adrenergic agonists and corticosteroid aerosols].
Spector S
Rev Alerg Mex; 1993; 40(6):i-iv. PubMed ID: 9296815
[No Abstract] [Full Text] [Related]
8. Beta-mimetic agents and other bronchodilating drugs in children.
Geubelle F; Mossay C
Acta Paediatr Belg; 1979; 32(2):79-88. PubMed ID: 40386
[No Abstract] [Full Text] [Related]
9. [Beta-2-agonists are still of value. Tolerance does not affect the bronchodilating effect].
Larsson K
Lakartidningen; 1997 Oct; 94(42):3741-2, 3745-6, 3749-50. PubMed ID: 9411129
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases].
Kazanbiev NK
Klin Med (Mosk); 1995; 73(4):24-7. PubMed ID: 7474811
[No Abstract] [Full Text] [Related]
11. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
12. [Bronchodilators: beta-sympathicomimetics].
van Herwaarden CL
Ned Tijdschr Geneeskd; 1986 Oct; 130(42):1876-8. PubMed ID: 2878376
[No Abstract] [Full Text] [Related]
13. [Bronchodilators, those marvelous drugs].
Perpiñá Tordera M; Lloris Bayo A
Arch Bronconeumol; 2004 Mar; 40 Suppl 1():16-22. PubMed ID: 16137445
[No Abstract] [Full Text] [Related]
14. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
López-Campos JL
Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
[No Abstract] [Full Text] [Related]
15. [Agonists of the beta adrenergic receptors of the bronchial tree].
Pacheco CR
Gac Med Mex; 1981 Dec; 117(12):474-5. PubMed ID: 6123461
[No Abstract] [Full Text] [Related]
16. [Beta 2-sympathomimetic drugs].
Criée CP; Laier-Groeneveld G
Internist (Berl); 1995 Sep; 36(9):918-23. PubMed ID: 7591618
[No Abstract] [Full Text] [Related]
17. [Beta-2 agonists in the therapy of obstructive airway diseases].
Solèr M
Praxis (Bern 1994); 1996 Sep; 85(38):1159-61. PubMed ID: 8927893
[No Abstract] [Full Text] [Related]
18. [Chronic bronchitis. Gold standard from the internet].
MMW Fortschr Med; 2001 Jun; 143(23):47. PubMed ID: 11460425
[No Abstract] [Full Text] [Related]
19. Bronchodilators: beta-agonists.
Goldie RG; Lulich KM; Paterson JW
Med J Aust; 1995 Jan; 162(2):100-2. PubMed ID: 7838013
[No Abstract] [Full Text] [Related]
20. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
Hughes AD; McNamara A; Steinfeld T
Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
